CID 16047979

Rabacfosadine

Structural Information

Molecular Formula
C21H35N8O6P
SMILES
CCOC(=O)[C@H](C)NP(=O)(COCCN1C=NC2=C(N=C(N=C21)N)NC3CC3)N[C@@H](C)C(=O)OCC
InChI
InChI=1S/C21H35N8O6P/c1-5-34-19(30)13(3)27-36(32,28-14(4)20(31)35-6-2)12-33-10-9-29-11-23-16-17(24-15-7-8-15)25-21(22)26-18(16)29/h11,13-15H,5-10,12H2,1-4H3,(H2,27,28,32)(H3,22,24,25,26)/t13-,14-/m0/s1
InChIKey
ANSPEDQTHURSFQ-KBPBESRZSA-N
Compound name
ethyl (2S)-2-[[2-[2-amino-6-(cyclopropylamino)purin-9-yl]ethoxymethyl-[[(2S)-1-ethoxy-1-oxopropan-2-yl]amino]phosphoryl]amino]propanoate
Related CIDs

2D Structure

compound 2d structure
4
Annotation Hits

17
References

74
Patents

526.2417 Da
Monoisotopic Mass

0.5
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 527.24898 222.1
[M+Na]+ 549.23092 224.7
[M-H]- 525.23442 223.8
[M+NH4]+ 544.27552 220.0
[M+K]+ 565.20486 221.1
[M+H-H2O]+ 509.23896 211.1
[M+HCOO]- 571.23990 243.9
[M+CH3COO]- 585.25555 256.9
[M+Na-2H]- 547.21637 220.6
[M]+ 526.24115 230.8
[M]- 526.24225 230.8
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe